Search Results - "Adani, Rellie"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase by Amitai, Gabriel, Gaidukov, Leonid, Adani, Rellie, Yishay, Shelly, Yacov, Guy, Kushnir, Moshe, Teitlboim, Shai, Lindenbaum, Michal, Bel, Peter, Khersonsky, Olga, Tawfik, Dan S., Meshulam, Haim

    Published in The FEBS journal (01-05-2006)
    “…We addressed the ability of various organophosphorus (OP) hydrolases to catalytically scavenge toxic OP nerve agents. Mammalian paraoxonase (PON1) was found to…”
    Get full text
    Journal Article
  2. 2

    The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from β-amyloid neurotoxicity by acting on Wnt signaling components by Farías, Ginny G., Godoy, Juan A., Vázquez, Mary C., Adani, Rellie, Meshulam, Haim, Avila, Jesús, Amitai, Gabi, Inestrosa, Nibaldo C.

    Published in Neurobiology of disease (01-02-2005)
    “…Changes in signal transduction are implicated in neuronal responses to the Alzheimer's amyloid-β-peptide (Aβ), which include neurotransmitter systems and…”
    Get full text
    Journal Article
  3. 3

    Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity by Amitai, Gabi, Adani, Rellie, Yacov, Guy, Yishay, Shelly, Teitlboim, Shai, Tveria, Liat, Limanovich, Osnat, Kushnir, Moshe, Meshulam, Haim

    Published in Toxicology (Amsterdam) (20-04-2007)
    “…Abstract In order to enhance the enzymatic detoxification rate of organophosphorus (OP) nerve agents we have searched for more active variants of recombinant…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments by Nizri, Eran, Adani, Rellie, Meshulam, Haim, Amitai, Gabi, Brenner, Talma

    Published in Neuroscience letters (07-03-2005)
    “…We tested two novel bifunctional compounds: ibuprofen- N-octyl-pyridostigmine bromide (IBU-PO) and ibuprofen- N-decyl-pyridostigmine bromide (IBU-PD). They…”
    Get full text
    Journal Article